Clinical Trial Update: Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial update on cardiac uptake of 18F Florbetapir in patients undergoing chemotherapy for cardiac amyloidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Drugs mentioned

• 18F Florbetapir

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Cardiac Amyloidosis | Phase 4 | Status: TERMINATED